Navigation Links
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
Date:12/11/2007

ith two late-stage clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), a Phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C, and a pre-clinical program directed at improving cardiovascular function.

Vernakalant (iv) is the intravenous formulation of an investigational drug being evaluated for the acute conversion of atrial fibrillation. Positive top-line results from two pivotal Phase 3 trials for vernakalant (iv), called ACT 1 and ACT 3, were released in December 2004 and September 2005. Cardiome's co-development partner Astellas Pharma US, Inc. submitted a New Drug Application for vernakalant (iv) in December 2006. Positive top-line results from an additional Phase 3 study evaluating patients with post-operative atrial arrhythmia, called ACT 2, were released in June 2007. An open-label safety study evaluating recent-onset AF patients, called ACT 4, has completed.

Vernakalant (oral) is being investigated as a chronic-use oral drug for the maintenance of normal heart rhythm following termination of AF. Cardiome announced positive results from a Phase 2a pilot study for vernakalant (oral) in September 2006. A Phase 2b study for vernakalant (oral) is ongoing.

In April 2007 Cardiome acquired exclusive worldwide rights for GED-aPC for all indications. Cardiome intends to initially develop GED-aPC in cardiogenic shock, a life-threatening form of acute circulatory failure due to cardiac dysfunction, which is a leading cause of death for patients hospitalized following a heart attack.

Cardiome is traded on the Toronto Stock Exchange (COM) and the NASDAQ National Market (CRME).

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... in the United States, named Mariah N. Manzanares, MD as the new Medical Director ... the new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, ...
(Date:7/3/2015)... , ... July 03, 2015 , ... The Celebrity Dresses ... cocktail dresses similar to those of celebrities will have the opportunity to get 10% ... checkout. This ensures that people do not have to use coupon codes or remember ...
(Date:7/2/2015)... ... ... the recent report by JAMA Internal Medicine published on June 22, 2015, ... declared a war on obesity in the United States. , "Obesity is one of ... magnitude of this discovery. For that reason, I am declaring, along with my Health ...
(Date:7/2/2015)... , ... July 02, 2015 , ... With summer in full swing, Americans are flocking ... one of the top spots for fishing in the world, and it’s easy to understand ... Ontario, Canada has great fish. , Recreational fishing is a huge industry, and Americans ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the socks were first ... and athletic trainers. Their significant popularity has inspired four new, fun shades including: ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2
... protein and the target for genistein, a dietary compound, in ... July 28 in the Journal of the National Cancer ... Bergan, M.D., of the Department of Medicine at Northwestern University ... prostate cancer cells by assessing cell invasion and gene and ...
... WASHINGTON, July 28 The American Dental Association (ADA) agrees with the ... restriction on the use of dental amalgam, a commonly used cavity-filling material. ... go to: http://www.prnewswire.com/mnr/ada/39331/ , , ... a class II medical device, placing it in the same class as ...
... , , ... Eleven innovative veterinary students from around the world were honored ... and wildlife. The students, whose projects were funded through Morris ... of their results at MAF,s annual meeting in June. Members ...
... NEW YORK, JULY 28 The American Society ... released the 2009 updated Interventional Pain Management (IPM) guidelines. , ... guidelines stated that, "The purpose of the IPM guidelines is ... of chronic or persistent pain, and provide information about the ...
... , SEATTLE, July 28 Cell ... today announced the closing of its previously announced public offering ... purchase up to 8,432,981 shares of its common stock, including ... received approximately $40.3 million in net proceeds from the offering, ...
... , , New FDA ... "silver" dental fillings , , WASHINGTON, July ... (FDA) today did an about face in issuing a final regulation ... and children. Last June, a court settlement filed by the Consumers ...
Cached Medicine News:Health News:Video: American Dental Association Statement: Food and Drug Administration Action on Dental Amalgam 2Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 2Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 3Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 4Health News:New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 2Health News:New Interventional Pain Management Guidelines Released by the American Society of Interventional Pain Physicians 3Health News:Cell Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Warrants 2Health News:FDA Ruling on Mercury Fillings Falls Short 2
(Date:7/2/2015)... de julio de 2015 BGI anunció hoy ... alto rendimiento en Hong Kong ... Pathologists (CAP). La instalación de BGI en Hong ... de próxima generación que recibe la certificación CAP en ... estándar en prácticas de laboratorio clínico. Junto con el ...
(Date:7/2/2015)... July 2, 2015   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade cell and tissue hypothermic storage ... cloud hosted biologistics cold chain management app for ... Seattle Business Magazine has included BioLife in its ... in Washington state for 2015. ...
(Date:7/2/2015)... , July 2, 2015   Wilson Therapeutics ... appointment of Hans Schikan to its board of directors. ... Annual General Meeting on June 30. "We ... directors," said Jonas Hansson , CEO of Wilson ... Wilson, and we look forward to his contributions to ...
Breaking Medicine Technology:BGI recibe la acreditación del College of American Pathologists (CAP) 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
... Owner Pleads Guilty; Dog Wardens Revoke,Snyder County Kennel ... officials are cracking down on unsatisfactory kennels with ... prosecutor and dog,wardens, Special Deputy Agriculture Secretary for ... dog wardens continue to make progress enforcing current,regulations. ...
... Corp.,(Nasdaq: GENZ ) announced today that the ... trial examining the safety and effectiveness of,Clolar(R) (clofarabine) ... leukemia (AML) who are unlikely to benefit from ... to provide substantial,evidence for expanding the current product ...
Cached Medicine Technology:Dog Law Officers' Crackdown on Unsatisfactory Kennels Protecting Animals, Consumers 2Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 2Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 3Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 4Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 5Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML 6
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: